相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Serum glial fibrillary acidic protein correlates with multiple sclerosis disease severity
Heidi Hogel et al.
MULTIPLE SCLEROSIS JOURNAL (2020)
Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis
Nelly Siller et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis
Nelly Siller et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
Blood neurofilament light chain as a biomarker of MS disease activity and treatment response
Jens Kuhle et al.
NEUROLOGY (2019)
Glial Activation Markers in CSF and Serum From Patients With Primary Progressive Multiple Sclerosis: Potential of Serum GFAP as Disease Severity Marker?
Ahmed Abdelhak et al.
FRONTIERS IN NEUROLOGY (2019)
Serum GFAP and neurofilament light as biomarkers of disease activity and disability in NMOSD
Mitsuru Watanabe et al.
NEUROLOGY (2019)
Association Between Serum Neurofilament Light Chain Levels and Long-term Disease Course Among Patients With Multiple Sclerosis Followed up for 12 Years
Ester Canto et al.
JAMA NEUROLOGY (2019)
Serum neurofilament light chain levels associations with gray matter pathology: a 5-year longitudinal study
Dejan Jakimovski et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2019)
Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis
Christian Barro et al.
BRAIN (2018)
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
Alan J. Thompson et al.
LANCET NEUROLOGY (2018)
Multiple Sclerosis
Daniel S. Reich et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Partial volume-aware assessment of multiple sclerosis lesions
Mario Joao Fartaria et al.
NEUROIMAGE-CLINICAL (2018)
Serum GFAP as a biomarker for disease severity in multiple sclerosis
A. Abdelhak et al.
SCIENTIFIC REPORTS (2018)
Science is 1% inspiration and 99% biomarkers
Nicolas Dubuisson et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Science is 1% inspiration and 99% biomarkers
Nicolas Dubuisson et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Serum Neurofilament Light: A Biomarker of Neuronal Damage in Multiple Sclerosis
Giulio Disanto et al.
ANNALS OF NEUROLOGY (2017)
Automated Detection of White Matter and Cortical Lesions in Early Stages of Multiple Sclerosis
Mario Joao Fartaria et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2016)
Glial and neuronal markers in cerebrospinal fluid in different types of multiple sclerosis
M. Alba Mane-Martinez et al.
JOURNAL OF NEUROIMMUNOLOGY (2016)
Neurofilament light in CSF and serum is a sensitive marker for axonal white matter injury in MS
Joakim Bergman et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2016)
Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis
M. Alba Mane Martinez et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis
M. Alba Mane Martinez et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Assessing tissue damage in multiple sclerosis: a biomarker approach
J. Burman et al.
ACTA NEUROLOGICA SCANDINAVICA (2014)
Automated segmentation of multiple sclerosis lesion subtypes with multichannel MRI
Ying Wu et al.
NEUROIMAGE (2006)
Neurofilament and glial fibrillary acidic protein in multiple sclerosis
N Norgren et al.
NEUROLOGY (2004)
分享论文
